Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Artificial pancreas Stories

2011-11-02 15:21:00

In Just 23 Days, Over 100,000 Individuals Sign Petition for the FDA to Advance, Not Delay, the Development of an Artificial Pancreas WASHINGTON, Nov. 2, 2011 /PRNewswire-USNewswire/ -- U.S. Senators, clinical experts, and people with type 1 diabetes (T1D) today urged the Food and Drug Administration (FDA) to issue clear and reasonable guidance on the artificial pancreas (AP) that avoids unnecessary delays in development and delivery of a medical technology and improves the lives of...

2011-10-26 07:00:00

PETACH TIKVAH, Israel, October 26, 2011 /PRNewswire/ -- At the initiative, and under the leadership of specialists in the Jesse Z and Sara Lea Shaffer Institute for Endocrinology and Diabetes, National Center of Childhood Diabetes, Schneider Children's Medical Center, an innovative trial project of the MD-Logic Artificial Pancreas (MDLAP) has successfully taken place in Israel. The aim of the trial was to provide a real solution to patients with diabetes, using the MDLAP in a...

2011-10-24 13:06:00

MIAMI, Oct. 24, 2011 /PRNewswire/ -- In a study to be presented at the CTS-IXA Congress today, Lorenzo Piemonti, M.D., the director of the islet transplantation program at the San Raffaele Diabetes Research Institute of Milan, will show Phase II clinical data that supports the development of Reparixin for use in pancreatic islet transplantation experimental procedure as an alternative to pancreas transplant in patients with advanced stages of Type 1 diabetes who develop a resistance...

2011-09-22 11:22:02

Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin The NHS has stumped up an extra £625 million over the past decade on synthetic forms of insulin, when the recommended human alternatives– which are considerably cheaper– would have probably been just as effective, reveals research published online in BMJ Open. The finding comes as a UN health summit in New York this week debates how to step up international efforts to...

2011-09-16 07:00:00

The product is a "smart cap" which, when added to a typical insulin pen, uses a timer to remind diabetics about when they're due for an insulin injection as reported by diabeticlive.com. Tampa, FL (PRWEB) September 16, 2011 âœSmart Capâ for Insulin Pens Reminds Diabetics When itâs Time for an Injection: Diabetics will soon have a new way to remind themselves to take insulin shots. A new product called Timesulin was recently announced at the...

2011-09-17 07:00:00

The Juvenile Diabetes Research Foundation (JDRF) announced on September 14 that it is holding a $100,000 Challenge for the development of a new glucose-sensitive insulin medication that will be used in the treatment of patients with diabetes as reported by diabeticlive.com. Tampa, FL (PRWEB) September 17, 2011 JDRF Offers $100,000 for Glucose-Responsive Insulin Medication: The Juvenile Diabetes Research Foundation (JDRF) announced on September 14 that it is holding a $100,000 Challenge for...

2011-09-12 14:17:33

Say Hebrew University researchers Researchers at the Hebrew University of Jerusalem have identified the key signal that prompts production of insulin-producing beta cells in the pancreas -- a breakthrough discovery that may ultimately help researchers find ways to restore or increase beta cell function in people with type 1 diabetes. The work on the multi-year project was led by Prof. Yuval Dor of the Institute for Medical Research Israel-Canada of the Hebrew University, researchers...

2011-09-08 07:00:00

PHILADELPHIA, Sept. 8, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing the Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, today announced that it is initiating a clinical study of its Symphony tCGM System. The company expects to complete and announce the results of the study in the near-term. "Initiating the clinical study of...

2011-08-01 14:33:51

Research published in The Cochrane Library found that the risk of death and cardiovascular disease, such as stroke, was unchanged whether glucose control was intense or conventional. They did find, however, that when aiming to keep blood glucose levels at the lower intensive level, the chance of damaging small blood vessels in the body, potentially leading to damage in the eyes and kidneys, is reduced. But aiming for this lower level with the more intensive glucose control substantially...

2011-07-20 12:47:00

JDRF says Pending Artificial Pancreas Guidance is FDA's Opportunity to Turn the Tide NEW YORK, July 20, 2011 /PRNewswire-USNewswire/ -- The Juvenile Diabetes Research Foundation (JDRF) welcomed Congress's attention today to the important issue of medical device regulatory reform and reiterated the life-changing difference the FDA's pending artificial pancreas guidance will make in the lives of millions of individuals with type 1 diabetes across the country. The hearing, "FDA Medical...